arrow
L

Luisa Lanfrancone

European Institute of Oncology IRCCS
H指数:43
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MyD88 sustains a metastasis-competent cell state by promoting integrin-mediated adhesion in melanoma

MyD88通过促进整合素介导的黏附维持黑色素瘤的转移前细胞状态

2026-10-150
OAAI
Nanoparticles-mediated dual drug administration boosts therapeutic efficacy in drug resistant melanoma

纳米颗粒介导的双药给药增强耐药性黑素瘤的疗效

2026-08-230
OA
Early tolerance and late persistence as alternative drug responses in cancer

早期耐受和晚期持续作为癌症中替代的药物反应

2025-02-030
OA
Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres (vol 22, 1, 2024)
2024-10-220
OAAI
Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion
2024-01-272
OAAI
Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres
2024-01-064
OAAI
TFEB and TFE3 drive kidney cystogenesis and tumorigenesis
2023-03-2911
OAAI
Targeting the MITF/APAF-1 axis as salvage therapy for MAPK inhibitors in resistant melanoma
2022-11-017
OA
The EurOPDX Research Infrastructure: Supporting European and worldwide cancer research with patient-derived xenografts
2020-08-150
PRE